Rectal use of nonoxynol-9 among men who have sex with men |
| |
Authors: | Mansergh Gordon Marks Gary Rader Melissa Colfax Grant N Buchbinder Susan |
| |
Affiliation: | Epidemiology Branch, Division of HIV/AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia 30333, USA. |
| |
Abstract: | OBJECTIVES: To assess recent rectal use of nonoxynol-9 (N-9), intent to use the product, and factors associated with N-9 use among men who have sex with men (MSM). DESIGN: Cross-sectional survey of a diverse sample of MSM in the San Francisco Bay Area. METHODS: Recruitment conducted at multiple street locations on various days/times or through referral during the Fall of 2001. RESULTS: Sixty-one percent (349/573) had heard of N-9, of which 55% (192/349) reported hearing in the prior year that N-9 may not be protective against HIV. Of men aware of N-9, 83% (289/349) knowingly used it in their lifetime, of which 67% (193/289) used it during anal intercourse in the previous year. Forty-one percent (79/193) of those who used N-9 during anal intercourse in the past year did so without a condom because they thought it may protect against HIV. Older men were more likely than younger men to have used N-9 for protection. Men who heard that N-9 may not protect were less likely, and African-Americans (versus Caucasians) were more likely, to say they would definitely use N-9 during anal intercourse in the future. Latinos (versus Caucasians), those with unknown HIV serostatus (versus HIV-negative), and those with lower education were less likely to know about N-9 at all, and thus were at risk for unknowingly using N-9. CONCLUSIONS: Many MSM used N-9 during or following public health warnings about the product. Actions (e.g., information campaigns, warning labels specific to rectal use) should be considered by communities to reduce rectal use of N-9. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|